The association between inflammation and endoplasmic reticulum (ER) stress has been described in many diseases. However, if and how chronic inflammation governs the unfolded protein response (UPR) and promotes ER homeostasis of chronic inflammatory disease remains elusive. In this study, chronic inflammation resulted in ER stress in mesenchymal stem cells in the setting of periodontitis. Long-term proinflammatory cytokines induced prolonged ER stress and decreased the osteogenic differentiation of periodontal ligament stem cells (PDLSCs). Interestingly, we showed that chronic inflammation decreases the expression of lysine acetyltransferase 6B (KAT6B, also called MORF), a histone acetyltransferase, and causes the upregulation of a key UPR sensor, PERK, which lead to the persistent activation of the UPR in PDLSCs. Furthermore, we found that the activation of UPR mediated by MORF in chronic inflammation contributes to the PERK-related deterioration of the osteogenic differentiation of PDLSCs both in vivo and in vitro. Taken together, our results suggest that chronic inflammation compromises UPR function through MORF-mediated-PERK transcription, which is a previously unrecognized mechanism that contributes to impaired ER function, prolonged ER stress and defective osteogenic differentiation of PDLSCs in periodontitis. Cell Death and Differentiation (2016) 23, 1862-1872 doi:10.1038/cdd.2016; published online 22 July 2016
The endoplasmic reticulum (ER) primarily functions in protein biosynthesis and folding, lipid trafficking, metabolism and intracellular calcium storage. Elevated physiological demand for protein folding can cause the accumulation of misfolded or unfolded proteins in the ER lumen, a state called ER stress. 1 The proper folding of proteins can be achieved by the unfolded protein response (UPR), which mitigates such ER stress and mediates cellular adaptation by an integrated signal transduction pathway through three canonical stress sensors located at the ER membrane: protein kinase RNA-like ER kinase (PERK), inositol-requiring protein 1 (IRE1) and activating transcription factor 6 (ATF6). 1, 2 Chronic inflammation is associated with UPR activation, while the chronic inflammatory microenvironment can give rise to a certain number of pathological conditions, including rheumatoid arthritis, diabetes, neurodegenerative and neuromuscular inflammatory diseases, and periodontitis. [3] [4] [5] [6] However, how chronic inflammation causes diseases and triggers ER stress has not been fully elucidated.
Periodontitis is a global widespread human chronic inflammatory disease. 6 Accumulating evidence has demonstrated that UPR-related genes are upregulated in periodontitis, which suggests an association between periodontitis and ER stress. [7] [8] [9] Periodontal ligament stem cells (PDLSCs) are a group of mesenchymal stem cells (MSCs) derived from the periodontal ligament 10, 11 that show tissue specificity and impaired differentiation capability and have a close relationship with periodontitis. [12] [13] [14] Controversial evidence was found in the regulation of the osteogenic differentiation of MSCs by 1 UPR activation. [15] [16] [17] [18] [19] [20] However, how ER stress results in the abnormal differentiation of PDLSCs remains largely unknown.
Histone acetyltransferases (HATs), such as MORF, 21, 22 have diverse functions, such as epigenetic control, 23, 24 transcriptional regulation, 25, 26 DNA replication 27 and cellular signaling, 28, 29 due to their distinct domains. Reports have revealed that MORF-deficient mice showed defects in cerebral and bone development, 30 which suggested that MORF plays a pivotal role in osteogenesis. Recent studies also showed that HATs could regulate UPR-related genes. [31] [32] [33] In this study, we observed ER stress in MSCs from periodontitis patients (P-PDLSCs). To further explore the role of ER stress in periodontitis-associated chronic inflammation, prolonged ER stress in MSCs from normal patients (H-PDLSCs) was induced by long-term treatment with proinflammatory cytokines. However, short-term treatment with proinflammatory cytokines could not sustain ER stress in H-PDLSCs. As described above, our study investigated the effects of longterm inflammation on the decrease of MORF expression in PDLSCs, which transcriptionally represses the expression of the UPR sensor PERK. In addition, ER stress impairs the osteogenic differentiation of PDLSCs. Notably, the decreased osteogenic differentiation of PDLSCs induced by ER stress is also mediated by the PERK pathway but not by IRE1 or ATF6.
Results

Activation of ER stress and the UPR target genes in
MSCs isolated from the chronic inflammatory microenvironment. We isolated H-PDLSCs and P-PDLSCs and characterized them by flow cytometry analysis. Both H-PDLSCs and P-PDLSCs expressed the surface markers of MSCs (Supplementary Figures S1A and B) . To investigate whether ER stress was induced in P-PDLSCs, we used transmission electron microscopy (TEM) analysis to observe the ER. Compared with H-PDLSCs (Figure 1a) , our results showed more dilated and abundant ER in P-PDLSCs (Figure 1b) . Meanwhile, we found continuous upregulation of the canonical UPR target genes PERK (also called EIF2AK3), GRP78 (HSPA5/BiP), GRP94 (HSP90B1/TRA1) and CHOP (DDIT3) 34 ( Figure 1c ) in three consecutive passages of P-PDLSCs compared with H-PDLSCs (Passage 2-4). These results indicate that the chronic inflammatory environment induces ER stress and subsequently produces the UPR in PDLSCs.
Chronic inflammation triggers the UPR and impairs the osteogenic differentiation of H-PDLSCs. To determine whether long-term inflammatory stimulation induces UPR in PDLSCs, we used interleukin-1 β (IL-1β) and tumor necrosis factor α (TNF-α), which are highly expressed in the periodontal microenvironment in patients, 14, 35, 36 to treat H-PDLSCs and observe the UPR response in the cells. After continuous exposure of H-PDLSCs using IL-1β (5 ng/ml; Figure 2a ) and TNF-α (10 ng/ml; Figure 2b ) treatment separately for 7 days, we observed the activation of UPR by real-time RT-PCR. Notably, we found that high levels of the UPR did not decrease in three consecutive passages (Passage 2-4) with the removal of the stimulus.
Our previous study showed the defective osteogenic differentiation of P-PDLSCs. 12, 13 To determine whether the inflammatory microenvironment results in the osteogenic impairment of PDLSCs, we tested the osteogenesis of H-PDLSCs treated with IL-1β and TNF-α separately. Western blot analysis and real-time RT-PCR showed that the osteogenic marker proteins and genes of runt-related transcription factor 2 (Runx2) and osteocalcin (OCN) of H-PDLSCs were decreased with IL-1β (Figure 2c and Supplementary Figures  S2A and B) and TNF-α (Figure 2d and Supplementary Figures  S2C and D) treatment, respectively. Alizarin red staining demonstrated that IL-1β-and TNF-α-treated cells formed fewer mineralization nodules (Figures 2e and f) . The apoptosis of P-PDLSCs and H-PDLSCs showed no significant difference at 6 h ( Supplementary Figures S3A and B) . After either TNF-α (10 ng/ml) or IL-1β (5 ng/ml) treatment, respectively, the apoptosis of H-PDLSCs was not increased compared with H-PDLSCs without treatment at 7 days (Supplementary Figures S3E-G). All these studies showed that chronic inflammation triggers the UPR and contributes to the deteriorative osteogenic differentiation of H-PDLSCs.
Periodontitis-associated chronic inflammation triggers UPR activation with MORF mediation. To evaluate whether inflammatory cytokines can induce the UPR after short-term stimulation, we conducted a series of time-course experiments with IL-1β-and TNF-α-treated H-PDLSCs. However, after 0-24 h of stimulation with IL-1β ( Figure 3a ) and TNF-α (Figure 3b ), we found that the expressions of the UPR target genes were increased at the earlier stage but were returned to the original level at the later stage (within 24 h). These results indicate that long-term stimulation by inflammation may cause transcriptional changes in PDLSCs, which results in UPR activation.
Because previous studies showed that HATs played an important role in ER stress, [31] [32] [33] we first screened the expressions of the HAT family in P-PDLSCs and H-PDLSCs. We identified that lysine acetyltransferase 2A (KAT2A), lysine acetyltransferase 3B (KAT3B), lysine acetyltransferase 6A (KAT6A) and MORF (also called KAT6B) of P-PDLSCs were reduced in the periodontitis-associated chronic inflammatory microenvironment (Supplementary Figure S4A) . To further assess which HAT activates the UPR, we used siRNA to knockdown the expression of the HATs and observe the UPR response. Western blot analysis showed that the MORF expression of H-PDLSCs was decreased after transfection with MORF siRNA (Figure 3c and Supplementary Figure S5A ). The findings revealed that knockdown of MORF resulted in higher expression of the UPR target genes PERK, activating transcription factor 4 (ATF4) and CHOP (Figure 3d) , which elucidated the activation of the UPR pathway, PERK. However, knockdown of KAT2A (Supplementary Figure S4B) , KAT3B (Supplementary Figure S4C) or KAT6A (Supplementary Figure S4D ) did not activate the UPR. We also found more dilated and abundant ER in MORF siRNA-transfected H-PDLSCs by TEM (Figure 3e ). To further elucidate the effect of MORF on ER stress, we overexpressed the MORF vector to transfect cells. We found that the overexpression of MORF decreased the expression of the UPR target genes PERK, ATF4 and CHOP (Figures 3f and g and Supplementary Figure S5B) . These results suggest that periodontitis-associated chronic inflammation triggers UPR activation with MORF mediation.
MORF represses PERK and impairs MSC osteogenic differentiation in periodontitis-associated chronic inflammation. We further explored the role of MORF in the chronic inflammation and osteogenic differentiation of PDLSCs. Over a long period of stimulation of 7 days, the expression of MORF was decreased in P-PDLSCs (Figure 4a UPR activation leads to the decreased osteogenic differentiation of PDLSCs. Because decreased expression of MORF increases PERK expression and activates the UPR response and impairs osteogenic differentiation of H-PDLSCs during chronic periodontitis, we sought to determine whether activated UPR also leads to impaired osteogenic differentiation of PDLSCs. Then, we treated PDLSCs with two UPR inducers, tunicamycin (Tm) and thapsigargin (Tg), and an inhibitor 4-phenyl butyric acid (4-PBA), before osteogenic induction. The results of real-time RT-PCR confirmed that all three UPR pathways were drastically increased with both the Tm (Figure 5a ) and Tg (Figure 5b) treatments for 6 h. However, the three UPR pathways of P-PDLSCs were decreased after 4-PBA treatment for 6 h (Figure 5c ). Moreover, Tm treatment resulted in greater upregulation of UPR genes, compared with Tg treatment.
Next, we used Tm, Tg and 4-PBA to treat PDLSCs separately in osteogenic induction. According to real-time RT-PCR and western blot analysis, the osteogenic marker proteins and genes of Runx2 and OCN of H-PDLSCs were decreased with both Tm (Figure 5d Figures S6E and F) . We also found that Tm (1 μg/ml) and Tg (1 μmol/l) treated PDLSCs showed no significant difference in cell apoptosis compared with the cells Figure S7C) . The formation of mineralization nodules was also increased in PERK siRNA-transfected P-PDLSCs compared with control siRNA-transfected P-PDLSCs (Figure 6d) . However, the osteogenic differentiation of P-PDLSCs was not rescued after transfection with IRE1 siRNA or ATF6 siRNA (Supplementary Figures S8E-N) .
Subsequently, to verify whether UPR activation causes bone loss and PERK inhibition rescues bone formation in vivo, we used Tm and Tg to induce alveolar bone loss in rats and the PERK inhibitor GSK2606414, which was found to be a specific inhibitor of PERK, [37] [38] [39] [40] to inhibit drug-induced bone loss. We injected 10 μl saline, 0.1 mg/ml Tm, 0.1 mmol/l Tg and Tm in combination with 10 μmol/l of the PERK inhibitor GSK2606414 into the maxillary palatal gingiva between the first and second upper molars of SD rats. We found that the Tm-treated group showed more bone loss than the other groups, as the highest distance from the cemento-enamel junction (CEJ) to the alveolar bone crest was observed in all the four sites (Figure 6e ). However, with the administration of Tm in combination of GSK2606414, the alveolar bone loss of two molars was noticeably reduced (Figure 6e). As described above, we demonstrate that ER stress regulates the osteogenic capacity of PDLSCs through PERK both in vitro and in vivo.
Discussion
In this study, we uncovered a previously unrecognized link between UPR signaling and MSC function in periodontitisassociated chronic inflammation. For the first time, we report that prolonged ER stress activates the UPR sensor PERK and then impairs MSC differentiation in the periodontitisassociated chronic inflammatory microenvironment. Meanwhile, as summarized in Figure 7 , we reveal the novel mediator role of MORF to the UPR, specifically in its expression and function.
Inflammation can activate the UPR according to different cell types. In murine fibrosarcoma L929 cells, TNF-α induced the UPR in a reactive oxygen species (ROS)-dependent fashion. 41 In demyelinating disorders and central nervous inflammation, interferon-γ (IFN-γ)-induced oligodendrocyte apoptosis was associated with the PERK-eIf2α pathway. 42 However, low concentrations of lipopolysaccharide (1 ng/ml) can inhibit the ATF4-CHOP pathways in mononuclear macrophages; 43, 44 therefore, further studies are needed to determine the dominant factors between the inflammatory environment and ER stress. Our study first observed the most obvious changes of ER morphology by TEM, which revealed ER stress in P-PDLSCs. Next, we used inflammatory cytokines to treat PDLSCs in vitro and proved that prolonged ER stress and the UPR can be triggered in the periodontal inflammatory environment.
The mechanism by which the inflammatory microenvironment causes ER stress and triggers the UPR is unclear, but several studies suggest that proinflammatory cytokines may induce the UPR in the accumulation of ROS and release Ca 2+ , which causes the accumulation of unfolded or misfolded proteins and mitochondrial dysfunction to induce ER stress. 41, 42 Diseases, such as type 2 diabetes, cystic fibrosis, inflammatory bowel disease and periodontitis, are reported to be associated with ER stress.
7-9,45-47 Therefore, it is crucial to determine the role of ER stress in inflammatory diseases. In our study, we used IL-1β and TNF-α, which have been proved to play crucial roles and be secreted mainly by monocytes in periodontal diseases, 14, 35, 36 to treat PDLSCs and mimic a long-term inflammatory microenvironment in vitro. Moreover, IL-1β and TNF-α have also been related to the UPR-mediated acute phase response. 48 Our data showed that the cytokineinduced UPR peaked in the first 12 h of treatment and then declined to pre-induction levels within 24 h. However, we found that the UPR response of PDLSCs still existed after removing the stimulation of proinflammatory cytokines and passing the cells to the next two continuing passages. These results led us to hypothesize that long-term stimulation by inflammation may cause transcriptional changes in PDLSCsand result in UPR activation.
Because previous studies showed that HATs play an important role in ER stress, [31] [32] [33] we turned our attention to the HAT family. After screening the entire HAT family, we isolated MORF, which conformed to our study. MORF deficiency in chronic inflammation triggers the UPR and results in high expression of PERK and its downstream genes ATF4 and CHOP in PDLSCs. MORF binding was found to be enriched in the promoter regions of PERK by CHIP analysis. Our results support the intriguing concept that inflammation decreases the expression of MORF, which acts as a transcriptional repressor in activating UPR. However, how chronic periodontitis causes persistent decreases in the expression of MORF still needs further study. The inflammatory microenvironment may regulate the expression of MORF by epigenetic modification or through the loop, in which paracrine factors of MSCs inhibit MORF expression. In addition, MORF possesses additional modules (such as PHD fingers), 49 which may mediate its binding to other transcription factors in UPR genes. This evidence illustrates the possibility that MORF may function with other transcription factors and act as a transcriptional coregulator.
Previous studies showed that UPR activation can regulate osteogenic differentiation of MSCs, but it remains controversial.
For example, the ER stress inducer ATF3 can suppress bone morphogenetic protein (BMP2)-induced alkaline phosphatase (ALP) expression in MC3T3-E1 cells. 18 However, in OS732 cells, fluoride-induced osteoblastic and osteoclastic differentiation was due to the activation of ALP and receptor activator for nuclear factor-κB ligand (RANKL) mediated by the PERK pathway, but had no effect on Runx2 and osteoprotegerin. 19 The alcohol-induced ER stress inhibited the osteogenesis of MSCs by suppressing the Wnt/β-catenin pathway, downregulating the Osf2/Cbfa1 gene, and activating TNF-α signaling by the PERK/ATF4/CHOP pathway. 20 Meanwhile, the induction of ER stress caused a loss of stemness in a PERK-eIF2α-dependent manner in intestinal stem cells. 50 In our study, because the inflammatory microenvironment also induced ER stress and the UPR response, we wondered whether the ER stress response of stem cells plays a pivotal role in regulating osteogenic differentiation. We performed the osteogenic differentiation assay in vitro, which showed that chronic inflammation led to the decreased osteogenic differentiation of PDLSCs. Moreover, we used siRNA transfection in vitro to further document the role of PERK pathway in mediating the osteogenic differentiation, but not other two branches of the UPR, IRE1 and ATF6. An experimental SD-rat periodontitis model was used to confirm the role of PERK in bone formation in vivo. Since the activated UPR may induce the apoptosis of PDLSCs, 51 which also contribute to the decreased bone formation. We tested the apoptosis of P-PDLSCs and found no significant difference in apoptosis between P-PDLSCs and H-PDLSCs at 6 h. The apoptosis of H-PDLSCs after either long-term TNFα or IL-1β treatment was not increased compared with H-PDLSCs without treatment at 7 days. These results suggested that chronic inflammation triggered UPR might not induce apoptosis of PDLSCs. As stated above, we drew the conclusion that UPR activation Figure 7 Schematic diagram shows that the mechanisms of decreased MORF lead to prolonged ER stress in periodontitis-associated chronic inflammation. Inflammatory cytokines compromise UPR function through MORF-mediated-PERK transcription, which contributes to impaired ER function, prolonged ER stress and defective osteogenic differentiation of PDLSCs in periodontitis-associated chronic inflammation regulates the osteogenic differentiation of PDLSCs through the PERK pathway.
In summary, our study revealed the mechanism by which chronic inflammation compromises UPR function through MORF-mediated-PERK transcription, which contributes to impaired ER function, prolonged ER stress and defective osteogenic differentiation of PDLSCs.
Materials and Methods
Cell culture. Healthy human tooth samples were obtained from 15 individuals, aged 25-40 years, from teeth that being extracted for orthodontic reasons. Periodontitis teeth were collected from 15 periodontitis patients aged 25-40 years. Patients diagnosed with periodontitis were defined as those with more than one periodontal pocket (depth46 mm), attachment loss (depth ≥ 5 mm) and alveolar bone loss (≥2/3). 6 Teeth were extracted at the Department of Periodontology, School of Stomatology, Fourth Military Medical University. Consent forms were obtained before conducting this research project. The experimental protocols were approved by the Hospital Ethics Committee (No. IRB-REV-2015005). The patients included in this study had no systemic diseases, did not smoke and took no special medications over the past year.
PDLSCs were isolated and cultured as previously described. 12, 52 Briefly, to obtain single-cell suspensions, periodontal ligament tissues were separated from the middle third of the root surface and digested in 3 mg/ml collagenase I (Sigma-Aldrich Corp, St Louis, MO, USA) for 2 h at 37°C. Cells were then plated in six-well culture dishes (Costar; Corning Inc., Corning, NY, USA) in α-minimal essential medium (α-MEM; Gibco BRL, Gaithersburg, MD, USA) with 10% fetal bovine serum (Hangzhou Sijiqing Biological Engineering Materials Co., Ltd, Zhejing, China), 0.292 mg/ml L-glutamine (Invitrogen Life Technology, Carlsbad, CA, USA), 100 units/ml penicillin (Invitrogen) and 100 mg/ml streptomycin (Invitrogen) at 37°C in 5% CO 2 . Cells were cultured for 2 weeks and the medium was changed every 3 days. Then, single-cell-derived colony cultures were obtained using the limiting dilution technique to further purify the stem cells. All colonies were then pooled and expanded. We used H-PDLSCs and P-PDLSCs at passage 2-5 (P2-P5). Each experiment used the same passage.
The ER stress inducers tunicamycin (Tm, 1 μg/ml) and thapsigargin (Tg, 1 μmol/l) and inhibitor 4-phenyl butyric acid (4-PBA, 5 mmol/l) were purchased from Sigma. H-PDLSCs (P3) were cultured in α-MEM additionally supplemented with Tm and Tg for 6 h; P-PDLSCs (P3) were cultured in α-MEM additionally supplemented with 4-PBA for 6 h. The inflammatory cytokines TNF-α (10 ng/ml) and IL-1β (5 ng/ml) were from Pepro-Tech (Rocky Hill, NJ, USA). For near-term stimulation, H-PDLSCs (P2) incubated with TNF-α or IL-1β were treated for 0, 3, 6, 9, 12 or 24 h. For longterm stimulation, H-PDLSCs, P-PDLSCs and H-PDLSCs (P2) incubated with TNF-α or IL-1β were cultured for 7 days and the medium was changed every other day. Then, the stimulus was removed and the same samples were passed to passage 3 to 4 and harvested for the following tests.
Flow cytometry. PDLSCs were stained with antibodies for stem cell surface markers and analyzed by flow cytometry as described previously. Briefly, to identify the phenotypes of PDLSCs, 10 6 cells per ml at passage 2 were incubated with phycoerythrin (PE)-conjugated monoclonal antibodies for human CD146 (Biolegend, San Diego, CA, USA), CD34, CD90, CD14 (eBioscience, San Diego, CA, USA) and fluorescein isothiocyanate (FITC)-conjugated monoclonal antibodies for STRO-1 (BioLegend) and CD105 (eBioscience) according to the manufacturer's instructions. The incubation procedure was carried out at 4°C for 1 h away from light. After washing with 3% PBS, cells were subjected to flow cytometric analysis (Beckman Coulter Inc., Fullerton, CA, USA).
About 10 6 cells were washed, trypsinized and centrifuged. The cells were labeled for 15 min with FITC-conjugated Annexin V (7Sea Pharmatech Co., Ltd, Shanghai, China) in culture medium (final concentration 0.1-1 mg/ml), then counterstained with 2 mg propidium iodide per ml culture medium (7Sea Pharmatech Co.). At least 20 000 cells were considered using the flow cytometric analysis (Beckman Coulter Inc.).
Vector construction and cell transfection. The MORF (GenBank Accession No. 23522) cDNA was amplified by PCR using the primer pairs: forward: 5′-GGGAGACCCAAGCTGGCTAGCGGCCACCATGGTAAAACTTGCAAACCCAC-3′; reverse: 5′-GCCCTCTAGACTCGAGCGGCCGCCCCTTCTCATGTAGGAGCCATTG-3′. And then, the restriction enzymes NheI and NotI were used to clone the above fragments into the backbone vector pcDNATM6/V5-His A/C vector backbone (Addgene, Cambridge, MA, USA) using a one-step cloning kit (C112-01, Clon Express; Vazyme Biotech Co., Ltd, Nan Jing, China). The overexpression vector pcDNATM6-MORF was constructed and transfected into the PDLSCs by Lipofectamine 2000 (Invitrogen).
To inhibit chaperone expression, cells were transfected with PERK, IRE1, ATF6, MORF, KAT2A, KAT6A and KAT3B siRNA conjugated with Lipofectamine 2000 for 6 h. All the agents were purchased from Santa Cruz (Santa Cruz, Dallas, TX, USA). The cells were incubated at 37°C in an incubator for 24-48 h before further assay.
Osteogenic differentiation in vitro. For osteogenic induction in vitro, cells were seeded on six-well culture dishes and cultured in the growth medium until the cells reached confluence. To induce osteogenic differentiation, the medium was changed to 100 μg/ml ascorbic acid, 2 mol/l β-glycerophosphate and 10 nmol/l dexamethasone (Sigma). One week after osteogenic induction, total RNA was extracted and analyzed for the presence of osteogenic genes by real-time RT-PCR. Total protein was extracted and analyzed for osteogenic markers by western blot after 14 days. After 28 days, calcium deposits formed by osteoblasts on the dishes were detected by staining with 1% Alizarin Red (Sigma). The medium was changed every 3 days, and experiments were performed in triplicate. The Alizarin red staining was performed as previously described. 53 For quantification analysis, Alizarin red staining was extracted with 1% cetylpyridinium chloride (Sigma) and measured with a spectrophotometer (Epoch; BioTek, Winooski, VT, USA) at 562 nm. The results were normalized to the total protein quantity of each sample to exclude the influence of cell numbers.
Real-time RT-PCR of mRNA. RNA was extracted using TRIzol (Invitrogen) according to the manufacturer's standard protocol. Random-primed cDNA was synthesized in a 20 μl reaction volume (Takara Bio, Shiga, Japan) for the reverse transcription of mRNA. The RT-PCR reactions were performed in a total volume of 10 μl using the SYBR Premix Ex TaqII kit (Takara) and detected on the CFX96 Real-Time System (Bio-Rad, Hercules, CA, USA). PCR was performed using standard settings: 94°C for 3 min; 94°C for 15 s and 60°C for 30 s repeated for 40 cycles, then the dissociation stage. Each assay was run in triplicate for technical variations. Arbitrary mRNA concentrations were calculated using the relative standard curve method. Gene expression levels were determined using the ΔΔ − c t method normalized to the reference gene GAPDH. All primer sequences used in this study are described in Supplementary Table S1 .
Western blot. The western blot analysis was performed as previously described. 12 Proteins were extracted with RIPA lysis buffer with protease inhibitor cocktail (Sigma) at 4°C. After centrifugation, the soluble protein in the extract was quantified by a G250 protein assay (Beyotime, Haimen, Jiangsu, China). Samples were loaded onto 10% Tris-glycine SDS-polyacrylamide gel (Invitrogen), transferred onto a PVDF membrane (Merck Millipore, Billerica, MA, USA) and blocked with 5% nonfat milk powder in PBST (PBS with 0.1% Tween). The membranes were incubated overnight at 4°C with the following primary antibodies. The primary antibodies for human Runx2 (Cell Signaling, Beverly, MA, USA), OCN (Santa Cruz), PERK (Cell Signaling), MORF (Abcam, Cambridge, MA, USA), IRE1 (Cell Signaling), ATF6 (Santa Cruz) and β-actin (Cowin Biotech, Beijing, China) were used in this study. The membranes were then incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (Cowin Biotech) at room temperature for 2 h. We visualized the signals by exposing the membrane to chemiluminescent HRP substrate (Thermo Scientific Inc., Rockford, IL, USA) using the Western-Light Chemiluminescent Detection System (Peiqing, Shanghai, China) according to the manufacturer's instructions.
TEM. Cells were washed with serum-free media and fixed with 4% glutaraldehyde and 4% paraformaldehyde (Sigma, both fixatTransives were diluted in phosphatebuffered saline, pH 7.2), dehydrated in a graded ethanol series and embedded in situ in an LX-812 resin (Ladd Research Industries Inc., Williston, VT, USA). Ultrathin sections were stained with uranyl acetate (30 min) and lead citrate (10 min) and observed by a FEI Tecnai G12 Spirit BioTwin transmission electron microscope (FEI Company, Hillsboro, Oregon, USA) with an accelerating voltage of 100 kV. Digital images were captured on a Veleta CCD camera (Olympus-SIS, Münster, Germany).
ChIP. We used a CHIP assay kit (Merck Millipore; Catalog 17-371) to confirm the binding between proteins and gene promoters according to the manufacturer's protocol. Normal rabbit IgG (Merck Millipore) was used as a negative control. We obtained the PERK promoter region sequence from Genebank (Gene ID: 9451). We chose the upstream 2000 base sequences of the CDS coding region of PERK and randomly allocated it for four sequences. We carried out ChIP analysis using the four sequences by real-time RT-PCR. The final result showed that only the second sequence of PERK promoter is effective. The primers of the promoter of PERK were: 5′-TGGTGCGATCTCAGCTCATTG-3′ (forward) and 5′-TGCCT GTAATCCCA GCCCTCT-3′ (reverse). All precipitated DNA samples were analyzed by real-time RT-PCR. The results were normalized to the input value, and all CHIP experiments were repeated at least three times.
Drug administration in experimental periodontitis of SpragueDawley (SD) rats. Experimental periodontitis was induced as previously described. 54 All animal procedures were performed according to the guidelines of the Animal Care Committee of the Fourth Military Medical University, Xi'an, China. Twelve 8-week-old SD rats were randomly distributed into four groups: Saline; Tm (0.1 mg/ml); Tg (0.1 mmol/l); Tm (0.1 mg/ml)+GSK2606414 (10 μmol/l, PERK inhibitor, purchased from Merck Millipore) with three rats per group. Then, 10 μl drugs were injected in each group into the maxillary palatal gingiva between the first and second upper molars and repeated every other day on three separate days. All rats were anesthetized and killed by exsanguination on day 7.
Micro-CT analysis. The whole head of SD rats was removed, and the maxillary jaws were scanned and analyzed using a micro-CT system (Siemens Inveon Micro-CT, Munich, Germany). After the mandibles were scanned, rebuilt images of the bone surface were used to perform three-dimensional histomorphometric analysis with the same density. From the rebuilt images, the alveolar bone height was measured at four different sites in two molars by recording the distance from the CEJ to the alveolar bone crest. The distances were assessed as the mean distance of experiment groups and were compared with the saline group with statistical analysis.
Histological analysis. The maxillary jaws were fixed with 4% paraformaldehyde for 24 h, decalcified with 10% ethylene diamine tetraacetic acid (pH 8.0) for 4 weeks and embedded in paraffin. Embedded specimens were then sectioned into 4-mm-thick sections. For histological and histomorphometric analysis, sections were deparaffinized and stained with hematoxylin and eosin (H&E) and observed under light and polarized microscopy (BX50; Olympus Optical).
Statistical analysis. All experiments were repeated at least three times and the results were similar between repeats. The data are presented as the mean ± S.D. The values between the two groups were calculated by independent two-tailed unpaired Student's t-test, and the values between multiple comparisons were assessed with analysis of variance (ANOVA) with the Bonferroni correction. All statistical analyses were performed using Graph Pad Prism 5.0 (GraphPad Software, La Jolla, CA, USA), and P-values less than 0.05 were considered statistically significant.
